Histogen Stock Total Debt
| HSTODelisted Stock | USD 0.74 0.10 15.62% |
Histogen fundamentals help investors to digest information that contributes to Histogen's financial success or failures. It also enables traders to predict the movement of Histogen Stock. The fundamental analysis module provides a way to measure Histogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Histogen stock.
Histogen |
Histogen Company Total Debt Analysis
Histogen's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Histogen Total Debt | 4.62 M |
Most of Histogen's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Histogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Histogen has a Total Debt of 4.62 M. This is 99.83% lower than that of the Biotechnology sector and 98.58% lower than that of the Health Care industry. The total debt for all United States stocks is 99.91% higher than that of the company.
Histogen Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Histogen's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Histogen could also be used in its relative valuation, which is a method of valuing Histogen by comparing valuation metrics of similar companies.Histogen is currently under evaluation in total debt category among related companies.
Histogen Fundamentals
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.44 | ||||
| Operating Margin | (638.32) % | ||||
| Current Valuation | (826.49 K) | ||||
| Shares Outstanding | 4.27 M | ||||
| Shares Owned By Insiders | 2.85 % | ||||
| Shares Owned By Institutions | 9.34 % | ||||
| Number Of Shares Shorted | 67.03 K | ||||
| Price To Book | 0.25 X | ||||
| Price To Sales | 1.11 X | ||||
| Revenue | 3.77 M | ||||
| Gross Profit | (1.25 M) | ||||
| EBITDA | (10.64 M) | ||||
| Net Income | (10.64 M) | ||||
| Cash And Equivalents | 12.6 M | ||||
| Cash Per Share | 5.04 X | ||||
| Total Debt | 4.62 M | ||||
| Debt To Equity | 0.31 % | ||||
| Current Ratio | 13.22 X | ||||
| Book Value Per Share | 2.18 X | ||||
| Cash Flow From Operations | (9.68 M) | ||||
| Short Ratio | 3.37 X | ||||
| Earnings Per Share | (3.79) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 2.0 | ||||
| Beta | 0.99 | ||||
| Market Capitalization | 2.91 M | ||||
| Total Asset | 19.07 M | ||||
| Retained Earnings | (88.27 M) | ||||
| Working Capital | 12.22 M | ||||
| Z Score | -6.98 | ||||
| Net Asset | 19.07 M |
About Histogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Histogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Histogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Histogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |